

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * killing of cells of other organism (GO:0031640) | 9.75785064 |
| 2 | * disruption of cells of other organism (GO:0044364) | 9.75785064 |
| 3 | * defense response to fungus (GO:0050832) | 9.58068131 |
| 4 | organ or tissue specific immune response (GO:0002251) | 9.51382271 |
| 5 | * antimicrobial humoral response (GO:0019730) | 9.44158104 |
| 6 | oxygen transport (GO:0015671) | 8.81019686 |
| 7 | protoporphyrinogen IX metabolic process (GO:0046501) | 8.13790346 |
| 8 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 7.64478858 |
| 9 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 7.63796798 |
| 10 | gas transport (GO:0015669) | 7.46465484 |
| 11 | detection of bacterium (GO:0016045) | 7.26044377 |
| 12 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 7.16674264 |
| 13 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 7.16674264 |
| 14 | response to peptidoglycan (GO:0032494) | 7.14894691 |
| 15 | detection of other organism (GO:0098543) | 7.11053898 |
| 16 | * response to fungus (GO:0009620) | 7.04151553 |
| 17 | intracellular estrogen receptor signaling pathway (GO:0030520) | 6.74051828 |
| 18 | hemoglobin metabolic process (GO:0020027) | 6.69393111 |
| 19 | defense response to Gram-positive bacterium (GO:0050830) | 5.96178163 |
| 20 | cellular extravasation (GO:0045123) | 5.77837599 |
| 21 | neutrophil activation (GO:0042119) | 5.69456081 |
| 22 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 5.54370324 |
| 23 | porphyrin-containing compound biosynthetic process (GO:0006779) | 5.47252584 |
| 24 | superoxide anion generation (GO:0042554) | 5.28889117 |
| 25 | negative regulation of interleukin-8 production (GO:0032717) | 5.24683164 |
| 26 | neutrophil activation involved in immune response (GO:0002283) | 5.21240578 |
| 27 | granulocyte activation (GO:0036230) | 5.15429636 |
| 28 | imidazole-containing compound metabolic process (GO:0052803) | 5.14775670 |
| 29 | negative regulation of growth of symbiont in host (GO:0044130) | 5.11401834 |
| 30 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 5.11401834 |
| 31 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 5.11401834 |
| 32 | regulation of growth of symbiont in host (GO:0044126) | 5.11401834 |
| 33 | * cell killing (GO:0001906) | 5.06165804 |
| 34 | leukocyte migration involved in inflammatory response (GO:0002523) | 5.02417968 |
| 35 | tetrapyrrole biosynthetic process (GO:0033014) | 4.74816247 |
| 36 | heme biosynthetic process (GO:0006783) | 4.73683349 |
| 37 | erythrocyte maturation (GO:0043249) | 4.64837784 |
| 38 | detection of external biotic stimulus (GO:0098581) | 4.60152604 |
| 39 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.50249447 |
| 40 | hydrogen peroxide catabolic process (GO:0042744) | 4.41236344 |
| 41 | porphyrin-containing compound metabolic process (GO:0006778) | 4.30605084 |
| 42 | regulation of natural killer cell differentiation (GO:0032823) | 4.29514349 |
| 43 | leukocyte aggregation (GO:0070486) | 4.18179618 |
| 44 | detection of biotic stimulus (GO:0009595) | 4.14232539 |
| 45 | response to methylmercury (GO:0051597) | 4.11955939 |
| 46 | erythrocyte development (GO:0048821) | 4.09767229 |
| 47 | myeloid cell development (GO:0061515) | 4.04327858 |
| 48 | citrulline biosynthetic process (GO:0019240) | 3.92794542 |
| 49 | * defense response to bacterium (GO:0042742) | 3.87204286 |
| 50 | heme metabolic process (GO:0042168) | 3.79947392 |
| 51 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.73582609 |
| 52 | neutrophil mediated immunity (GO:0002446) | 3.71561493 |
| 53 | negative regulation of interleukin-6 production (GO:0032715) | 3.54775901 |
| 54 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.45144069 |
| 55 | leukotriene biosynthetic process (GO:0019370) | 3.44598474 |
| 56 | * response to bacterium (GO:0009617) | 3.40582007 |
| 57 | respiratory burst (GO:0045730) | 3.39621111 |
| 58 | regulation of mast cell degranulation (GO:0043304) | 3.36463680 |
| 59 | megakaryocyte development (GO:0035855) | 3.34161238 |
| 60 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.28082099 |
| 61 | response to host immune response (GO:0052572) | 3.28082099 |
| 62 | leukotriene metabolic process (GO:0006691) | 3.11627738 |
| 63 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.11314966 |
| 64 | negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556) | 3.10647855 |
| 65 | activated T cell proliferation (GO:0050798) | 3.10124251 |
| 66 | regulation of leukocyte degranulation (GO:0043300) | 3.10031727 |
| 67 | regulation of response to osmotic stress (GO:0047484) | 3.09493746 |
| 68 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.09463331 |
| 69 | * modification of morphology or physiology of other organism (GO:0035821) | 3.07687905 |
| 70 | hydrogen peroxide metabolic process (GO:0042743) | 3.03397958 |
| 71 | response to host (GO:0075136) | 2.92756189 |
| 72 | response to host defenses (GO:0052200) | 2.92756189 |
| 73 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.92756189 |
| 74 | phagosome maturation (GO:0090382) | 2.87596712 |
| 75 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.84222944 |
| 76 | neutrophil chemotaxis (GO:0030593) | 2.83444775 |
| 77 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.83245156 |
| 78 | leukocyte degranulation (GO:0043299) | 2.82782035 |
| 79 | positive regulation of granulocyte differentiation (GO:0030854) | 2.79498864 |
| 80 | myeloid leukocyte mediated immunity (GO:0002444) | 2.78409755 |
| 81 | regulation of regulated secretory pathway (GO:1903305) | 2.77812398 |
| 82 | neutrophil migration (GO:1990266) | 2.76360289 |
| 83 | regulation of female gonad development (GO:2000194) | 2.74903352 |
| 84 | positive regulation of B cell differentiation (GO:0045579) | 2.74891483 |
| 85 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.74248324 |
| 86 | mast cell activation (GO:0045576) | 2.73699235 |
| 87 | regulation of mast cell activation (GO:0033003) | 2.72667397 |
| 88 | pentose-phosphate shunt (GO:0006098) | 2.71413000 |
| 89 | regulation of interleukin-8 production (GO:0032677) | 2.71128173 |
| 90 | superoxide metabolic process (GO:0006801) | 2.70455204 |
| 91 | bicarbonate transport (GO:0015701) | 2.69355198 |
| 92 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.68590296 |
| 93 | cellular response to interleukin-6 (GO:0071354) | 2.67721516 |
| 94 | definitive hemopoiesis (GO:0060216) | 2.65877489 |
| 95 | granulocyte migration (GO:0097530) | 2.64794897 |
| 96 | regulation of erythrocyte differentiation (GO:0045646) | 2.63474522 |
| 97 | tetrapyrrole metabolic process (GO:0033013) | 2.60038953 |
| 98 | innate immune response in mucosa (GO:0002227) | 12.2793559 |
| 99 | * antibacterial humoral response (GO:0019731) | 10.2339206 |
| 100 | mucosal immune response (GO:0002385) | 10.1600570 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GATA1_22025678_ChIP-Seq_K562_Human | 5.09696623 |
| 2 | SCL_19346495_ChIP-Seq_HPC-7_Human | 4.30021201 |
| 3 | GATA1_19941826_ChIP-Seq_K562_Human | 4.20409909 |
| 4 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.87889950 |
| 5 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.84936180 |
| 6 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.54930307 |
| 7 | VDR_24763502_ChIP-Seq_THP-1_Human | 3.52218028 |
| 8 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.23491803 |
| 9 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.03407577 |
| 10 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 2.91440280 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.73055637 |
| 12 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.72239086 |
| 13 | GATA2_19941826_ChIP-Seq_K562_Human | 2.67825688 |
| 14 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.64047109 |
| 15 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.62516493 |
| 16 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 2.59041033 |
| 17 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.53502237 |
| 18 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.53401715 |
| 19 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.39049967 |
| 20 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.34205675 |
| 21 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.31035677 |
| 22 | SPI1_23127762_ChIP-Seq_K562_Human | 2.30306791 |
| 23 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 2.29299600 |
| 24 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.27025814 |
| 25 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.25445249 |
| 26 | MYC_22102868_ChIP-Seq_BL_Human | 2.18973742 |
| 27 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.18534746 |
| 28 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.15331901 |
| 29 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.15163861 |
| 30 | UTX_26944678_Chip-Seq_JUKART_Human | 2.06509640 |
| 31 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 2.01658435 |
| 32 | MAF_26560356_Chip-Seq_TH1_Human | 2.01025360 |
| 33 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.97203965 |
| 34 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.96970144 |
| 35 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.95568388 |
| 36 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.87920401 |
| 37 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.84422842 |
| 38 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.83432140 |
| 39 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.83057918 |
| 40 | MYB_26560356_Chip-Seq_TH2_Human | 1.81502581 |
| 41 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.81175585 |
| 42 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.80021999 |
| 43 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.76756613 |
| 44 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.73139532 |
| 45 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.72213100 |
| 46 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.69992700 |
| 47 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.68364463 |
| 48 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.66974138 |
| 49 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.64730771 |
| 50 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.63988086 |
| 51 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.56511780 |
| 52 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.55821038 |
| 53 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.53176621 |
| 54 | MYB_26560356_Chip-Seq_TH1_Human | 1.52779822 |
| 55 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.52392480 |
| 56 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.52030865 |
| 57 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.48777620 |
| 58 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.41885059 |
| 59 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.41598172 |
| 60 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.41535791 |
| 61 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.41483186 |
| 62 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.38671803 |
| 63 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.38000186 |
| 64 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.36771000 |
| 65 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.36526477 |
| 66 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.36506625 |
| 67 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.35296106 |
| 68 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.32396264 |
| 69 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.30645589 |
| 70 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.28545381 |
| 71 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.25528717 |
| 72 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.23569853 |
| 73 | MAF_26560356_Chip-Seq_TH2_Human | 1.23415490 |
| 74 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.21776740 |
| 75 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.21180055 |
| 76 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.19954260 |
| 77 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19080757 |
| 78 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.16079120 |
| 79 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.15531937 |
| 80 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.15446789 |
| 81 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.14943842 |
| 82 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.14923969 |
| 83 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.12411592 |
| 84 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.09353504 |
| 85 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.04912263 |
| 86 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02105685 |
| 87 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.01995919 |
| 88 | P68_20966046_ChIP-Seq_HELA_Human | 1.01859661 |
| 89 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00917406 |
| 90 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99754635 |
| 91 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.98156142 |
| 92 | GATA3_26560356_Chip-Seq_TH2_Human | 0.96858592 |
| 93 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.96333100 |
| 94 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.92046946 |
| 95 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.91957138 |
| 96 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91918123 |
| 97 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.90391773 |
| 98 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.90266955 |
| 99 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.86964489 |
| 100 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.80181429 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004147_increased_porphyrin_level | 6.39848305 |
| 2 | MP0003656_abnormal_erythrocyte_physiolo | 5.83429262 |
| 3 | MP0003303_peritoneal_inflammation | 4.85681445 |
| 4 | MP0009785_altered_susceptibility_to | 3.57067962 |
| 5 | MP0003436_decreased_susceptibility_to | 3.30751855 |
| 6 | MP0009278_abnormal_bone_marrow | 3.22955556 |
| 7 | MP0002419_abnormal_innate_immunity | 3.01412858 |
| 8 | MP0005025_abnormal_response_to | 3.00426878 |
| 9 | MP0001545_abnormal_hematopoietic_system | 2.83647542 |
| 10 | MP0005397_hematopoietic_system_phenotyp | 2.83647542 |
| 11 | MP0005464_abnormal_platelet_physiology | 2.80133472 |
| 12 | MP0005083_abnormal_biliary_tract | 2.79804732 |
| 13 | MP0003724_increased_susceptibility_to | 2.39337399 |
| 14 | MP0003172_abnormal_lysosome_physiology | 2.34771662 |
| 15 | MP0001835_abnormal_antigen_presentation | 2.14676274 |
| 16 | MP0000685_abnormal_immune_system | 2.04978099 |
| 17 | MP0008260_abnormal_autophagy | 1.94593279 |
| 18 | MP0002398_abnormal_bone_marrow | 1.92235783 |
| 19 | MP0002420_abnormal_adaptive_immunity | 1.90108294 |
| 20 | MP0005000_abnormal_immune_tolerance | 1.86751586 |
| 21 | MP0001819_abnormal_immune_cell | 1.86706653 |
| 22 | MP0000465_gastrointestinal_hemorrhage | 1.84219636 |
| 23 | MP0003828_pulmonary_edema | 1.79882544 |
| 24 | MP0003191_abnormal_cellular_cholesterol | 1.74866002 |
| 25 | MP0003045_fibrosis | 1.74443221 |
| 26 | MP0005387_immune_system_phenotype | 1.71017962 |
| 27 | MP0001790_abnormal_immune_system | 1.71017962 |
| 28 | MP0004808_abnormal_hematopoietic_stem | 1.70282025 |
| 29 | MP0002722_abnormal_immune_system | 1.65833886 |
| 30 | MP0002405_respiratory_system_inflammati | 1.65755538 |
| 31 | MP0001533_abnormal_skeleton_physiology | 1.65598171 |
| 32 | MP0005058_abnormal_lysosome_morphology | 1.65145641 |
| 33 | MP0002452_abnormal_antigen_presenting | 1.63216330 |
| 34 | MP0000689_abnormal_spleen_morphology | 1.61218551 |
| 35 | MP0001800_abnormal_humoral_immune | 1.60672449 |
| 36 | MP0002723_abnormal_immune_serum | 1.54859694 |
| 37 | MP0001851_eye_inflammation | 1.54067178 |
| 38 | MP0002429_abnormal_blood_cell | 1.49356309 |
| 39 | MP0000716_abnormal_immune_system | 1.49153828 |
| 40 | MP0002396_abnormal_hematopoietic_system | 1.48972569 |
| 41 | MP0001845_abnormal_inflammatory_respons | 1.43058270 |
| 42 | MP0002148_abnormal_hypersensitivity_rea | 1.42802524 |
| 43 | MP0009764_decreased_sensitivity_to | 1.41840970 |
| 44 | MP0002009_preneoplasia | 1.37871444 |
| 45 | MP0002166_altered_tumor_susceptibility | 1.37542798 |
| 46 | MP0003300_gastrointestinal_ulcer | 1.35956129 |
| 47 | MP0009333_abnormal_splenocyte_physiolog | 1.35538563 |
| 48 | MP0002132_abnormal_respiratory_system | 1.33281083 |
| 49 | MP0005076_abnormal_cell_differentiation | 1.25306740 |
| 50 | MP0004947_skin_inflammation | 1.24414976 |
| 51 | MP0003075_altered_response_to | 1.23004744 |
| 52 | MP0006082_CNS_inflammation | 1.13096659 |
| 53 | MP0000703_abnormal_thymus_morphology | 1.10803332 |
| 54 | MP0003763_abnormal_thymus_physiology | 1.10630153 |
| 55 | MP0003566_abnormal_cell_adhesion | 1.10431561 |
| 56 | MP0005636_abnormal_mineral_homeostasis | 1.09896241 |
| 57 | MP0005671_abnormal_response_to | 1.08823180 |
| 58 | MP0002138_abnormal_hepatobiliary_system | 1.08482677 |
| 59 | MP0004185_abnormal_adipocyte_glucose | 1.04463681 |
| 60 | MP0010155_abnormal_intestine_physiology | 1.04109767 |
| 61 | MP0008469_abnormal_protein_level | 0.97021765 |
| 62 | MP0009931_abnormal_skin_appearance | 0.96812630 |
| 63 | MP0000343_altered_response_to | 0.94707102 |
| 64 | MP0005164_abnormal_response_to | 0.94668585 |
| 65 | MP0009765_abnormal_xenobiotic_induced | 0.90842205 |
| 66 | MP0009763_increased_sensitivity_to | 0.90555669 |
| 67 | MP0004883_abnormal_blood_vessel | 0.88027582 |
| 68 | MP0000858_altered_metastatic_potential | 0.88023139 |
| 69 | MP0001663_abnormal_digestive_system | 0.84627952 |
| 70 | MP0004510_myositis | 0.80703720 |
| 71 | MP0003795_abnormal_bone_structure | 0.75764750 |
| 72 | MP0004130_abnormal_muscle_cell | 0.75148194 |
| 73 | MP0002006_tumorigenesis | 0.73350332 |
| 74 | MP0000609_abnormal_liver_physiology | 0.72658883 |
| 75 | MP0000249_abnormal_blood_vessel | 0.72344787 |
| 76 | MP0001853_heart_inflammation | 0.71615491 |
| 77 | MP0000015_abnormal_ear_pigmentation | 0.70600610 |
| 78 | MP0002998_abnormal_bone_remodeling | 0.70386046 |
| 79 | MP0001986_abnormal_taste_sensitivity | 0.67889464 |
| 80 | MP0004381_abnormal_hair_follicle | 0.67538132 |
| 81 | MP0005075_abnormal_melanosome_morpholog | 0.66971144 |
| 82 | MP0003221_abnormal_cardiomyocyte_apopto | 0.66372269 |
| 83 | MP0002095_abnormal_skin_pigmentation | 0.64378910 |
| 84 | MP0003111_abnormal_nucleus_morphology | 0.64027135 |
| 85 | MP0002019_abnormal_tumor_incidence | 0.63931777 |
| 86 | MP0008775_abnormal_heart_ventricle | 0.63525814 |
| 87 | MP0004264_abnormal_extraembryonic_tissu | 0.60454750 |
| 88 | MP0000598_abnormal_liver_morphology | 0.60261458 |
| 89 | MP0005390_skeleton_phenotype | 0.60136630 |
| 90 | MP0002877_abnormal_melanocyte_morpholog | 0.58993082 |
| 91 | MP0005319_abnormal_enzyme/_coenzyme | 0.56077174 |
| 92 | MP0005166_decreased_susceptibility_to | 0.54715306 |
| 93 | MP0001849_ear_inflammation | 0.54570393 |
| 94 | MP0008004_abnormal_stomach_pH | 0.53886567 |
| 95 | MP0003183_abnormal_peptide_metabolism | 0.52275558 |
| 96 | MP0003806_abnormal_nucleotide_metabolis | 0.51959588 |
| 97 | MP0005621_abnormal_cell_physiology | 0.50571237 |
| 98 | MP0000490_abnormal_crypts_of | 0.50098193 |
| 99 | MP0000749_muscle_degeneration | 0.48738967 |
| 100 | MP0005165_increased_susceptibility_to | 0.47734439 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypochromic anemia (HP:0001931) | 6.90916139 |
| 2 | Poikilocytosis (HP:0004447) | 6.51011579 |
| 3 | Microcytic anemia (HP:0001935) | 6.10505442 |
| 4 | Abnormal hemoglobin (HP:0011902) | 5.47833974 |
| 5 | Polycythemia (HP:0001901) | 5.43917885 |
| 6 | Recurrent abscess formation (HP:0002722) | 4.70583999 |
| 7 | Eczematoid dermatitis (HP:0000976) | 4.61030139 |
| 8 | Recurrent bacterial skin infections (HP:0005406) | 4.58619957 |
| 9 | Paralysis (HP:0003470) | 4.49261692 |
| 10 | Toxemia of pregnancy (HP:0100603) | 4.41144182 |
| 11 | Prolonged bleeding time (HP:0003010) | 4.40643854 |
| 12 | Cholelithiasis (HP:0001081) | 4.31588177 |
| 13 | Abnormal gallbladder morphology (HP:0012437) | 3.87252921 |
| 14 | Abnormality of macrophages (HP:0004311) | 3.76028929 |
| 15 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.75845873 |
| 16 | Diaphragmatic weakness (HP:0009113) | 3.68287385 |
| 17 | Abnormality of iron homeostasis (HP:0011031) | 3.63303639 |
| 18 | Chronic obstructive pulmonary disease (HP:0006510) | 3.58646380 |
| 19 | Obstructive lung disease (HP:0006536) | 3.58646380 |
| 20 | Petechiae (HP:0000967) | 3.57206762 |
| 21 | Reticulocytosis (HP:0001923) | 3.57142537 |
| 22 | Epistaxis (HP:0000421) | 3.38911129 |
| 23 | Abnormal platelet volume (HP:0011876) | 3.34248960 |
| 24 | Stomatitis (HP:0010280) | 3.34001825 |
| 25 | Acanthocytosis (HP:0001927) | 3.13265080 |
| 26 | Abnormality of transition element cation homeostasis (HP:0011030) | 3.05255312 |
| 27 | Increased mean platelet volume (HP:0011877) | 3.00388677 |
| 28 | Urticaria (HP:0001025) | 2.98568456 |
| 29 | Myositis (HP:0100614) | 2.90972153 |
| 30 | Osteomyelitis (HP:0002754) | 2.83746994 |
| 31 | Systemic lupus erythematosus (HP:0002725) | 2.83698708 |
| 32 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.82664226 |
| 33 | Recurrent skin infections (HP:0001581) | 2.78977798 |
| 34 | Abnormality of the gallbladder (HP:0005264) | 2.78090565 |
| 35 | Gingivitis (HP:0000230) | 2.77883190 |
| 36 | Gastrointestinal infarctions (HP:0005244) | 2.77239710 |
| 37 | Mediastinal lymphadenopathy (HP:0100721) | 2.76994221 |
| 38 | Ileus (HP:0002595) | 2.73088273 |
| 39 | Gingival bleeding (HP:0000225) | 2.71828035 |
| 40 | Meningitis (HP:0001287) | 2.70773906 |
| 41 | Recurrent fungal infections (HP:0002841) | 2.69726540 |
| 42 | Increased cerebral lipofuscin (HP:0011813) | 2.53517524 |
| 43 | Cellulitis (HP:0100658) | 2.51180258 |
| 44 | Abnormality of the fingertips (HP:0001211) | 2.48969717 |
| 45 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.43936283 |
| 46 | Menorrhagia (HP:0000132) | 2.43415180 |
| 47 | Purpura (HP:0000979) | 2.35823873 |
| 48 | Thrombophlebitis (HP:0004418) | 2.34387148 |
| 49 | Hepatosplenomegaly (HP:0001433) | 2.34203274 |
| 50 | Granulocytopenia (HP:0001913) | 2.33234458 |
| 51 | Abnormal gallbladder physiology (HP:0012438) | 2.32916630 |
| 52 | Cholecystitis (HP:0001082) | 2.32916630 |
| 53 | Abnormal platelet function (HP:0011869) | 2.32639731 |
| 54 | Impaired platelet aggregation (HP:0003540) | 2.32639731 |
| 55 | Abnormality of reticulocytes (HP:0004312) | 2.31187021 |
| 56 | Spontaneous hematomas (HP:0007420) | 2.28968596 |
| 57 | Recurrent cutaneous fungal infections (HP:0011370) | 2.26753609 |
| 58 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.26753609 |
| 59 | Pallor (HP:0000980) | 2.24521334 |
| 60 | Increased serum ferritin (HP:0003281) | 2.24000844 |
| 61 | Increased IgE level (HP:0003212) | 2.22441782 |
| 62 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.21124974 |
| 63 | Autoimmune thrombocytopenia (HP:0001973) | 2.19689584 |
| 64 | Keratoconjunctivitis sicca (HP:0001097) | 2.19565842 |
| 65 | Amyloidosis (HP:0011034) | 2.17923542 |
| 66 | Cutaneous photosensitivity (HP:0000992) | 2.17625188 |
| 67 | Anorexia (HP:0002039) | 2.16394356 |
| 68 | Hyperbilirubinemia (HP:0002904) | 2.15610841 |
| 69 | Recurrent viral infections (HP:0004429) | 2.11554908 |
| 70 | Hypertensive crisis (HP:0100735) | 2.09108771 |
| 71 | Orchitis (HP:0100796) | 2.08085943 |
| 72 | Paresthesia (HP:0003401) | 2.08025217 |
| 73 | Nausea (HP:0002018) | 2.04861385 |
| 74 | Pustule (HP:0200039) | 2.01251165 |
| 75 | Hypochromic microcytic anemia (HP:0004840) | 12.1087942 |
| 76 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 11.5810527 |
| 77 | Retrobulbar optic neuritis (HP:0100654) | 1.98389554 |
| 78 | Optic neuritis (HP:0100653) | 1.98389554 |
| 79 | Keratoconjunctivitis (HP:0001096) | 1.98056566 |
| 80 | Vasculitis (HP:0002633) | 1.96904947 |
| 81 | Leukocytosis (HP:0001974) | 1.95308518 |
| 82 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.93656953 |
| 83 | Encephalitis (HP:0002383) | 1.91444416 |
| 84 | Episodic fever (HP:0001954) | 1.89939992 |
| 85 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.89026104 |
| 86 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.89026104 |
| 87 | Abnormality of glycolipid metabolism (HP:0010969) | 1.89026104 |
| 88 | Increased density of long bones (HP:0006392) | 1.87378920 |
| 89 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.87216253 |
| 90 | Chest pain (HP:0100749) | 1.87174845 |
| 91 | Hemoptysis (HP:0002105) | 1.86753714 |
| 92 | Skin rash (HP:0000988) | 1.86038564 |
| 93 | Abnormality of the pericardium (HP:0001697) | 1.85993253 |
| 94 | Thrombocytosis (HP:0001894) | 1.80962774 |
| 95 | Pulmonary infiltrates (HP:0002113) | 1.80115271 |
| 96 | Hepatocellular carcinoma (HP:0001402) | 1.79408664 |
| 97 | Cerebral palsy (HP:0100021) | 1.78831734 |
| 98 | Hypoparathyroidism (HP:0000829) | 1.76983902 |
| 99 | Skin ulcer (HP:0200042) | 1.75970745 |
| 100 | Bruising susceptibility (HP:0000978) | 1.74369299 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP2K3 | 4.92837306 |
| 2 | RIPK4 | 4.44872730 |
| 3 | PRPF4B | 4.24780678 |
| 4 | GRK6 | 3.60649723 |
| 5 | TAOK1 | 3.00021421 |
| 6 | BLK | 2.94996288 |
| 7 | TAOK2 | 2.63119943 |
| 8 | FES | 2.56166530 |
| 9 | MAP3K3 | 2.54946395 |
| 10 | MAP3K11 | 2.43811936 |
| 11 | TNK2 | 2.16948075 |
| 12 | SYK | 2.13650348 |
| 13 | TEC | 2.12427324 |
| 14 | MAP3K6 | 2.02825000 |
| 15 | IRAK4 | 2.01363493 |
| 16 | ZAP70 | 1.92473425 |
| 17 | MAP4K1 | 1.90534705 |
| 18 | ERN1 | 1.87318813 |
| 19 | BTK | 1.85067519 |
| 20 | EIF2AK1 | 1.81536264 |
| 21 | FGR | 1.79926564 |
| 22 | TYK2 | 1.62755662 |
| 23 | LYN | 1.38112373 |
| 24 | PIK3CG | 1.28452654 |
| 25 | PTK2B | 1.28366062 |
| 26 | HCK | 1.27476877 |
| 27 | YES1 | 1.22351616 |
| 28 | JAK2 | 1.17864592 |
| 29 | CSK | 1.17422680 |
| 30 | MAP3K5 | 1.16872240 |
| 31 | MAP3K14 | 1.13868151 |
| 32 | MAP3K1 | 1.11990623 |
| 33 | CLK1 | 1.00143030 |
| 34 | KIT | 0.99039860 |
| 35 | TRPM7 | 0.97438199 |
| 36 | MARK3 | 0.96156743 |
| 37 | MAP3K13 | 0.95426379 |
| 38 | ITK | 0.95187026 |
| 39 | MAP2K4 | 0.94532656 |
| 40 | MAPK12 | 0.93901738 |
| 41 | KDR | 0.89716186 |
| 42 | PIK3CA | 0.88836155 |
| 43 | TRIB3 | 0.85354719 |
| 44 | BMX | 0.81818366 |
| 45 | DAPK2 | 0.80589728 |
| 46 | EPHB1 | 0.79639980 |
| 47 | TXK | 0.76019455 |
| 48 | PDPK1 | 0.74407145 |
| 49 | RPS6KL1 | 0.72822911 |
| 50 | RPS6KC1 | 0.72822911 |
| 51 | CDK6 | 0.72087781 |
| 52 | LCK | 0.70616371 |
| 53 | TESK2 | 0.70178613 |
| 54 | HIPK2 | 0.68669413 |
| 55 | PDK1 | 0.68051909 |
| 56 | KSR2 | 0.67616150 |
| 57 | CDK12 | 0.66763706 |
| 58 | CSF1R | 0.65691930 |
| 59 | IRAK1 | 0.64713349 |
| 60 | JAK3 | 0.63577888 |
| 61 | TGFBR2 | 0.62290072 |
| 62 | TBK1 | 0.61555910 |
| 63 | MAPK4 | 0.61345483 |
| 64 | SMG1 | 0.61011321 |
| 65 | IKBKE | 0.60283858 |
| 66 | RPS6KA6 | 0.59964802 |
| 67 | MARK2 | 0.59675577 |
| 68 | MAP2K1 | 0.59375620 |
| 69 | PIM1 | 0.58874746 |
| 70 | RET | 0.57300490 |
| 71 | CDK19 | 0.54632052 |
| 72 | MAPK7 | 0.51757889 |
| 73 | STK10 | 0.50219541 |
| 74 | FYN | 0.49802584 |
| 75 | TTN | 0.49522533 |
| 76 | MAP2K6 | 0.48827894 |
| 77 | JAK1 | 0.47990079 |
| 78 | CAMK1D | 0.47985249 |
| 79 | STK11 | 0.44948172 |
| 80 | CDK4 | 0.43731757 |
| 81 | MAP3K8 | 0.43375835 |
| 82 | LRRK2 | 0.42932286 |
| 83 | RPS6KA2 | 0.42647979 |
| 84 | MAP2K2 | 0.40912577 |
| 85 | WNK1 | 0.40397663 |
| 86 | TIE1 | 0.40341227 |
| 87 | STK4 | 0.39799383 |
| 88 | MAP3K10 | 0.39335890 |
| 89 | SGK3 | 0.38642814 |
| 90 | EPHA3 | 0.38084618 |
| 91 | IKBKB | 0.36375576 |
| 92 | PRKCQ | 0.36204008 |
| 93 | PTK6 | 0.35848189 |
| 94 | BMPR2 | 0.35684163 |
| 95 | MAPKAPK2 | 0.33972023 |
| 96 | MAP3K7 | 0.33302145 |
| 97 | PDK2 | 0.31511487 |
| 98 | PRKAA2 | 0.31381012 |
| 99 | KSR1 | 0.30804634 |
| 100 | IRAK2 | 0.29879367 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 5.10836790 |
| 2 | Malaria_Homo sapiens_hsa05144 | 4.07896985 |
| 3 | Asthma_Homo sapiens_hsa05310 | 3.85340441 |
| 4 | African trypanosomiasis_Homo sapiens_hsa05143 | 3.23470330 |
| 5 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 2.73421450 |
| 6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.32112119 |
| 7 | Leishmaniasis_Homo sapiens_hsa05140 | 2.20691539 |
| 8 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.14140787 |
| 9 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.10219830 |
| 10 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.93740355 |
| 11 | Other glycan degradation_Homo sapiens_hsa00511 | 1.80463065 |
| 12 | Tuberculosis_Homo sapiens_hsa05152 | 1.79848131 |
| 13 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.63889840 |
| 14 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.54280773 |
| 15 | Platelet activation_Homo sapiens_hsa04611 | 1.53595556 |
| 16 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.52912199 |
| 17 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.47422326 |
| 18 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.42905505 |
| 19 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.41729680 |
| 20 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.39735478 |
| 21 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.34691688 |
| 22 | Legionellosis_Homo sapiens_hsa05134 | 1.31698727 |
| 23 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.27644595 |
| 24 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.25543497 |
| 25 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.24876649 |
| 26 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.24375701 |
| 27 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.23792910 |
| 28 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.22466172 |
| 29 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.20869920 |
| 30 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.19035556 |
| 31 | Phagosome_Homo sapiens_hsa04145 | 1.06783984 |
| 32 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.04378795 |
| 33 | Amoebiasis_Homo sapiens_hsa05146 | 1.03516365 |
| 34 | Lysosome_Homo sapiens_hsa04142 | 1.02395321 |
| 35 | Hepatitis B_Homo sapiens_hsa05161 | 1.01833192 |
| 36 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.01762547 |
| 37 | Pertussis_Homo sapiens_hsa05133 | 1.01759551 |
| 38 | Influenza A_Homo sapiens_hsa05164 | 1.01579060 |
| 39 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.01076092 |
| 40 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.95809599 |
| 41 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.94882419 |
| 42 | Measles_Homo sapiens_hsa05162 | 0.93802575 |
| 43 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.91672784 |
| 44 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.90289425 |
| 45 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.90154277 |
| 46 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.89580301 |
| 47 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.89023251 |
| 48 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.85477619 |
| 49 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.85015276 |
| 50 | Hepatitis C_Homo sapiens_hsa05160 | 0.80476913 |
| 51 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.80162106 |
| 52 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.79878272 |
| 53 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.79402552 |
| 54 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.77159301 |
| 55 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.70484188 |
| 56 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.69260657 |
| 57 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.68025979 |
| 58 | Shigellosis_Homo sapiens_hsa05131 | 0.67956331 |
| 59 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.67912192 |
| 60 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.66810505 |
| 61 | Salmonella infection_Homo sapiens_hsa05132 | 0.65781215 |
| 62 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.65317431 |
| 63 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.65284806 |
| 64 | Apoptosis_Homo sapiens_hsa04210 | 0.62985571 |
| 65 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.61766062 |
| 66 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.59761543 |
| 67 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.59189444 |
| 68 | Bladder cancer_Homo sapiens_hsa05219 | 0.58568868 |
| 69 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.58048712 |
| 70 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.53091550 |
| 71 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.52906099 |
| 72 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.52426606 |
| 73 | Endometrial cancer_Homo sapiens_hsa05213 | 0.51903017 |
| 74 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.51748995 |
| 75 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.51464831 |
| 76 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.50675194 |
| 77 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.49956669 |
| 78 | ABC transporters_Homo sapiens_hsa02010 | 0.49568935 |
| 79 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.48693672 |
| 80 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.47772458 |
| 81 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.47067742 |
| 82 | Glioma_Homo sapiens_hsa05214 | 0.46562568 |
| 83 | Prostate cancer_Homo sapiens_hsa05215 | 0.46178141 |
| 84 | Salivary secretion_Homo sapiens_hsa04970 | 0.45863145 |
| 85 | Galactose metabolism_Homo sapiens_hsa00052 | 0.44755231 |
| 86 | Endocytosis_Homo sapiens_hsa04144 | 0.44626046 |
| 87 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.44573482 |
| 88 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.44563764 |
| 89 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.44317335 |
| 90 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.43660196 |
| 91 | Allograft rejection_Homo sapiens_hsa05330 | 0.43179699 |
| 92 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.42218472 |
| 93 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.41372662 |
| 94 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.40448142 |
| 95 | Insulin resistance_Homo sapiens_hsa04931 | 0.40431765 |
| 96 | HTLV-I infection_Homo sapiens_hsa05166 | 0.40073411 |
| 97 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.39162325 |
| 98 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.38922891 |
| 99 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.38825173 |
| 100 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.38779201 |

